Novartis Pharmaceuticals UK Limited have informed MPD Voice that as of Friday 16th August 2013, Jakavi (Ruxolitinib) tablets will be packaged in blister packs, the formulation of the tablets will remain the same, it is just the packaging that has changed. If you have any concerns regarding this, in the first instance please speak to the pharmacist where your tablets are dispensed, if you still have concerns please email us at info@mpdvoice.org.uk.
Ruxolitinib (Jakavi) change to packaging - MPN Voice
Ruxolitinib (Jakavi) change to packaging
Written by
Mazcd
Partner
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Ruxolitinib
Husband has PV and MPN currently on Ruxolitinib which for him has been amazing and life saving....
Important opportunity to comment on NICE draft decision re Ruxolitinib for MF patients
THE DEADLINE IS TODAY - TUESDAY 10 NOVEMBER - for commenting on this decision by NICE, please...
Ruxolitinib
Hi all, I have PV and AB is high , around 81% , spleen size slightly increased but if I didn’t know...
Hematoma and Ruxolitinib
Hi. I am looking for advice or reassurance. I am on Ruxolitinib and aspirin. I am also taking...
Jakavi. - PV
Hi … can anyone tell me “why” jakavi is easily accessible and affordable in the U.K. ??? Or even...
Jakavi and Valaciclovir
Jakavi 
Ruxolitinib 
Procaine and Jakavi interactions
